Insights into the pathogenesis of ATP1A1 ‐related CMT disease using patient‐specific iPSCs
- 9 November 2019
- journal article
- research article
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 24 (4), 330-339
- https://doi.org/10.1111/jns.12357
Abstract
Background and aims The development of patient‐specific induced pluripotent stem cells (iPSCs) offered interesting insights in modeling the pathogenesis of Charcot‐Marie‐Tooth (CMT) disease and thus we decided to explore the phenotypes of iPSCs derived from a single CMT patient carrying a mutant ATP1A1 allele (p.Pro600Ala). iPSCs clones generated from CMT and control fibroblasts, were induced to differentiate into neural precursors and then into post‐mitotic neurons. Control iPSCs differentiated into neuronal precursors and then into post‐mitotic neurons within 6‐8 days. On the contrary, the differentiation of CMT iPSCs was clearly defective. Electrophysiological properties confirmed that post‐mitotic neurons were less mature compared to the normal counterpart. The impairment of in vitro differentiation of CMT iPSCs only concerned with the neuronal pathway, because they were able to differentiate into mesendodermal cells and other ectodermal derivatives. ATP1A1 was undetectable in the few neuronal cells derived from CMT iPSCs. Interpretation ATP1A1 gene mutation (p.Pro600Ala), responsible for a form of axonal CMT disease, is associated in vitro with a dramatic alteration of the differentiation of patient‐derived iPSCs into post‐mitotic neurons. Thus, the defect in neuronal cell development might lead in vivo to a decreased number of mature neurons in ATP1A1‐CMT disease.Funding Information
- Compagnia di San Paolo (6‐CSP‐UNINA‐120)
- Fondazione Telethon (GGP15113)
This publication has 23 references indexed in Scilit:
- Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathyNeurology Genetics, 2018
- Variant pathogenicity evaluation in the community-driven Inherited Neuropathy Variant BrowserHuman Mutation, 2018
- Mutations in ATP1A1 Cause Dominant Charcot-Marie-Tooth Type 2American Journal of Human Genetics, 2018
- Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCsStem Cell Reports, 2017
- Analysis of neural crest cells from Charcot–Marie–Tooth disease patients demonstrates disease-relevant molecular signatureNeuroReport, 2017
- HDAC6 Inhibitors Rescued the Defective Axonal Mitochondrial Movement in Motor Neurons Derived from the Induced Pluripotent Stem Cells of Peripheral Neuropathy Patients with HSPB1 MutationStem Cells International, 2016
- Towards a functional pathology of hereditary neuropathiesActa Neuropathologica, 2016
- Selective mitochondrial depletion, apoptosis resistance, and increased mitophagy in human Charcot-Marie-Tooth 2A motor neuronsHuman Molecular Genetics, 2016
- Charcot-Marie-Tooth diseaseNeurology, 2015
- Axonal Charcot–Marie–Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological propertiesExperimental Neurology, 2015